ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
InveniAI Announces Successful Completion of Milestone in its Collaboration with PRISM BioLab Focused on Designing Novel Inflammasome-Targeted Therapeutic Candidates
July 22, 2021InveniAI® LLC (InveniAI) today announced the successful completion of the first milestone in its collaboration with PRISM BioLab Co. Ltd, (PRISM), a biotechnology company with proprietary small-molecule drug discovery technology. -
Servier and PRISM BioLab enter drug discovery collaboration for a novel target
June 18, 2021Servier and PRISM BioLab, a Japan based biotechnology company with proprietary small molecule drug discovery platform, “PepMetics™Technology”, today announced that they have entered into a Collaboration and Exclusive License Option Agreement.
Pharma Sources Insight January 2025
